About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Notice of 2015 Annual General Meeting

April 22, 2015

Click here to read more

Post navigation

Appendix 3X Notices – Three New Directors

2014 Annual Report

Related Posts

Ethics Approval to Commence Topical TPM®/Oxycodone Patch Trial

December 8, 2014

Phosphagenics Signs Japanese License Option Agreement and R&D Alliance

April 29, 2016

Phosphagenics Initiates Grower/Finisher Pig Study

December 3, 2015

Recent Posts

First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
MEDIA | Channel 9 News
March 28, 2024
Avecho’s Phase III Clinical Trial for Insomnia Commences
March 26, 2024

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.